EMS-CHEMIE holds the cleaner structural position, with profitability as the main driver and valuation adding further support. Bristol-Myers Squibb Company still leads on growth and valuation, which keeps the comparison from looking entirely one-sided. The market setup is broadly comparable for both — no clear directional signal from price behavior. The market is not adding a decisive signal either way — the structural read carries the weight.
The comparison is based on similar long-term financial trajectories, not sector labels.
Profitability still does most of the heavy lifting in this comparison.
These two companies are linked by measured long-term financial trajectory similarity within the selected peer universe.
The pair shares a valid long-term profile match, but the trajectories are not especially close.
The clearest structural overlap shows up in investment intensity and operating margin level.
Scores reflect position relative to comparable companies with similar long-term financial trajectories.
The clearest separation appears in profitability.
Left means cheaper relative valuation. Higher means stronger structure.
The price setup looks more supportive for EMS-CHEMIE HOLDING AG, but Bristol-Myers Squibb Company still has the stronger structure.
Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.
Capital efficiency adds support, with a 21.3-point ROIC advantage.
Absolute pricing still looks more supportive for Bristol-Myers Squibb Company, with a forward P/E that is 19.1 turns lower there.
Profitability points more clearly to EMS-CHEMIE HOLDING AG, but valuation and current pricing keep the broader result mixed.
Break down the BMY vs EMSN.SW comparison across all dimensions with the full interactive tool.
Explore how BMY and EMSN.SW each compare against other companies in their peer groups.
Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.
AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.
Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.
Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.